IGF-1 increases with hyperbaric oxygen therapy and promotes wound healing in diabetic foot ulcers

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Aydin, Figen ^a,b   Kaya, Ahmet ^c   Karapinar, Levent ^c   Kumbaraci, Mert ^c   Imerci, Ahmet ^c   Karapinar, Hasan ^c   Karakuzu, Cengiz ^a   Incesu, Mustafa ^c  

^a Neoks Hyperbaric Oxygen Therapy Center   (Turkey)

^b Underwater and Hyperbaric Medicine   (Turkey)

^c Tepecik Training and Research Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; SOMATOMEDIN C;

ADULT; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; DIABETIC FOOT; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERBARIC OXYGEN; KLEBSIELLA; MALE; PERIPHERAL VASCULAR DISEASE; PREDICTIVE VALUE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TREATMENT RESPONSE; WOUND HEALING;

EID: 84879375288     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/567834     Document Type: Article

References (18)

1. Blakytny R., Jude E. B., Gibson J. M., Lack of insulin-like growth factor 1 in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers. The Journal of Pathology 2000 190 589 594 (Pubitemid 30164489)
2. Chen S. J., Yu C. T., Cheng Y. L., Yu S. Y., Lo H. C., Effects of hyperbaric oxygen therapy on circulating interleukin-8, nitric oxide, and insulin-like growth factors in patients with type 2 diabetes mellitus. Clinical Biochemistry 2007 40 1-2 30 36 2-s2.0-33845760087 10.1016/j.clinbiochem.2006.07. 007 (Pubitemid 46014153)
3. Chisalita S. I., Arnqvist H. J., Expression and function of receptors for insulin-like growth factor-I and insulin in human coronary artery smooth muscle cells. Diabetologia 2005 48 10 2155 2161 2-s2.0-26244441717 10.1007/s00125-005-1890-4 (Pubitemid 41416929)
4. Eskes A. M., Ubbink D. T., Lubbers M. J., Lucas C., Vermeulen H., Hyperbaric oxygen therapy: Solution for difficult to heal acute wounds? Systematic review. World Journal of Surgery 2011 35 3 535 542 2-s2.0-79952190653 10.1007/s00268-010-0923-4
5. Janssen J. A. M. J. L., Lamberts S. W. J., Circulating IGF-I and its protective role in the pathogenesis of diabetic angiopathy. Clinical Endocrinology 2000 52 1 1 9 2-s2.0-0033977868 10.1046/j.1365-2265.2000.00922.x (Pubitemid 30108277)
6. Janssen J. A. M. J. L., Lamberts S. W. J., The role of IGF-I in the development of cardiovascular disease in type 2 diabetes mellitus: is prevention possible? European Journal of Endocrinology 2002 146 4 467 477 2-s2.0-0036224924 (Pubitemid 34436457)
7. Kaya A., Aydin F., Altay T., Karapinar L., Ozturk H., Karakuzu C., Can major amputation rates be decreased in diabetic foot ulcers with hyperbaric oxygen therapy? International Orthopaedics 2009 33 2 441 446 2-s2.0-64249159699 10.1007/s00264-008-0623-y
8. Löndahl M., Katzman P., Nilsson A., Hammarlund C., Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care 2010 33 5 998 1003 2-s2.0-77954915401 10.2337/dc09-1754
9. Löndahl M., Landin-Olsson M., Katzman P., Hyperbaric oxygen therapy improves health-related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine 2011 28 2 186 190 2-s2.0-78651107409 10.1111/j.1464-5491.2010.03185.x
10. Muniyappa R., Walsh M. F., Rangi J. S., Zayas R. M., Standley P. R., Ram J. L., Sowers J. R., Insulin growth factor 1 increases vascular smooth muscle nitric oxide production. Life Sciences 1997 61 9 925 931 2-s2.0-0030877286 10.1016/S0024-3205(97)00594-8 (Pubitemid 27339072)
11. O'Reilly D., Linden R., Fedorko L., Tarride J. E., Jones W. G., Bowen J. M., Goeree R., A prospective, double-blind, randomized, controlled clinical trial comparing standard wound care with adjunctive hyperbaric oxygen therapy (HBOT) to standard wound care only for the treatment of chronic, non-healing ulcers of the lower limb in patients with diabetes mellitus: a study protocol. Trials 2011 12 69 79
12. Pennisi P. A., Barr V., Nunez N. P., Stannard B., Le Roith D., Reduced expression of insulin-like growth factor I receptors in MCF-7 breast cancer cells leads to a more metastatic phenotype. Cancer Research 2002 62 22 6529 6537 2-s2.0-0037112511 (Pubitemid 35364118)
13. Pöykkö S. M., Ukkola O., Kauma H., Kellokoski E., Hörkkö S., Kesäniemi Y. A., The negative association between plasma ghrelin and IGF-I is modified by obesity, insulin resistance and type 2 diabetes. Diabetologia 2005 48 2 309 316 2-s2.0-17444367645 10.1007/s00125-004- 1635-9 (Pubitemid 40543304)
14. Romero-Valdovinos M., Cardenas-Mejia A., Gutierrez-Gomez C., Keloid skin scars: the influence of hyperbaric oxygenation on fibroblast growth and on the expression of messenger RNA for insulin like growth factor and for transforming growth factor. In Vitro Cellular & Developmental Biology 2011 47 421 424 10.1007/s11626-011-9418-3
15. Schippinger G., Oettl K., Fankhauser F., Influence of intramuscular application of autologous conditioned plasma on systemic circulating IGF-1. Journal of Sports Science and Medicine 2011 10 439 444
16. Todorovic V., Pesko P., Micev M., Insulin-like growth factor-I in wound healing of rat skin. Regulatory Peptides 2008 150 7 13
17. Urso M. L., Fiatarone Singh M. A., Ding W., Evans W. J., Cosmas A. C., Manfredi T. G., Exercise training effects on skeletal muscle plasticity and IGF-1 receptors in frail elders. Age 2005 27 2 117 125 2-s2.0-33745624857 10.1007/s11357-005-1629-7 (Pubitemid 43982183)
18. Wallander M., Brismar K., Öhrvik J., Rydén L., Norhammar A., Insulin-like growth factor I: a predictor of long-term glucose abnormalities in patients with acute myocardial infarction. Diabetologia 2006 49 10 2247 2255 2-s2.0-33748507778 10.1007/s00125-006-0386-1 (Pubitemid 44359084)